Skip to main content

Find Clinical Trials

Home
Conditions
Mononegavirales Infections

Clinical trial condition

Mononegavirales Infections

Explore clinical trials studying Mononegavirales Infections. Study availability and eligibility vary by location and protocol.

541 public trials 34 recruiting studies

Refine in advanced search Browse all conditions

Mononegavirales Infections trial results

Completed

Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers

NCT00483574

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +35 more
Locations: Birmingham, Alabama, United States

Birmingham, Alabama, United States

Dothan, Alabama, United States

Pinson, Alabama, United States

View all 79 locations

View Trial Details

Completed

RSV001 - A New Vaccine to Prevent Severe Viral Chest Infections.

NCT01805921

Conditions: Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations: Centre for Clinical Vaccinology & Tropical Medicine (CCVTM) Oxford, Oxfordshire, United Kingdom

View Trial Details

Completed

Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers

NCT00422292

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +35 more
Locations: Tuscaloosa, Alabama, United States

Tucson, Arizona, United States

Jonesboro, Arkansas, United States

Little Rock, Arkansas, United States

View all 88 locations

View Trial Details

Completed

A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers

NCT00384397

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +35 more
Locations: Montgomery, Alabama, United States

Fayetteville, Arkansas, United States

Jonesboro, Arkansas, United States

Little Rock, Arkansas, United States

View all 39 locations

View Trial Details

Completed

Safety Study of Rabies Vaccine INDIRAB® Five Doses (0.5ml) Post Exposure Administered Intramuscularly

NCT02729168

Conditions: Infections, Mononegavirales Infections, RNA Virus Infections, +3 more
Locations: Cho Gao Health Centre Chợ Gạo, Tien Giang, Vietnam

View Trial Details

Completed

A Clinical Trial on the Candidate Vaccine cAd3-EBOZ in Healthy Adults in Switzerland

NCT02289027

Conditions: Ebola Vaccines, Filoviridae Infections, Hemorrhagic Fever, Ebola, +5 more
Locations: Clinical Trial Unit Lausanne Lausanne, Switzerland

View Trial Details

Completed

Efficacy of Favipiravir Against Severe Ebola Virus Disease

NCT02662855

Conditions: Ebola Virus Disease, Filoviridae Infections, Hemorrhagic Fever, Ebola, +5 more
Locations: Not specified

View Trial Details

Completed

The Safety Research of Freeze-dried Rabies Vaccine（MRC-5 Cell) in Chinese Humans

NCT02281396

Conditions: Healthy, Infections, Mononegavirales Infections, +4 more
Locations: Not specified

View Trial Details

Completed

Safety and Immunogenicity Study of Recombinant Human Rabies Immunoglobin (rhRIG) in Combination With Rabies Vaccine for Human Use With Human Rabies Immune Globulin (HRIG) in Combination With Rabies Vaccine for Human Use in Healthy Adult Subjects.

NCT02559921

Conditions: Infections, Mononegavirales Infections, RNA Virus Infections, +3 more
Locations: Not specified

View Trial Details

Completed

Evaluation of the FilmArray BioThreat-E Test

NCT02658331

Conditions: Ebola Virus Disease, Filoviridae Infections, Hemorrhagic Fever, Ebola, +5 more
Locations: Not specified

View Trial Details